Table of Contents
ISRN Oncology
Volume 2011, Article ID 948174, 5 pages
http://dx.doi.org/10.5402/2011/948174
Research Article

In Colorectal Liver Metastases, the Presence of Extrahepatic Disease Correlates with the Pathology of the Primary Tumour

Westmead Hospital, Sydney, NSW 2145, Australia

Received 23 February 2011; Accepted 18 March 2011

Academic Editor: L. Saragoni

Copyright © 2011 Saleh Abbas and Vincent Lam. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Scheele, R. Stangl, and A. Altendorf-Hofmann, “Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history,” British Journal of Surgery, vol. 77, no. 11, pp. 1241–1246, 1990. View at Publisher · View at Google Scholar · View at Scopus
  2. C. M. Schüssler-Fiorenza, D. M. Mahvi, J. Niederhuber, L. F. Rikkers, and S. M. Weber, “Clinical risk score correlates with yield of PET scan in patients with colorectal hepatic metastases,” Journal of Gastrointestinal Surgery, vol. 8, no. 2, pp. 150–158, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. F. G. Fernandez, J. A. Drebin, D. C. Linehan, F. Dehdashti, B. A. Siegel, and S. M. Strasberg, “Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET),” Annals of Surgery, vol. 240, no. 3, pp. 438–450, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. D. L. Joyce, R. L. Wahl, P. V. Patel, R. D. Schulick, S. L. Gearhart, and M. A. Choti, “Preoperative positron emission tomography to evaluate potentially resectable hepatic colorectal metastases,” Archives of Surgery, vol. 141, no. 12, pp. 1220–1226, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. R. H. Huebner, K. C. Park, J. E. Shepherd et al., “A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer,” Journal of Nuclear Medicine, vol. 41, no. 7, pp. 1177–1189, 2000. View at Google Scholar · View at Scopus
  6. M. C. B. Tan, E. T. Castaldo, F. Gao et al., “A prognostic system applicable to patients with resectable liver metastasis from colorectal carcinoma staged by positron emission tomography with [18F] fluoro-2-deoxy-D-glucose: role of primary tumor variables,” Journal of the American College of Surgeons, vol. 206, no. 5, pp. 857–868, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. T. M. Pawlik, L. Assumpcao, J. A. Vossen et al., “Trends in nontherapeutic laparotomy rates in patients undergoing surgical therapy for hepatic colorectal metastases,” Annals of Surgical Oncology, vol. 16, no. 2, pp. 371–378, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. K. S. H. Chok and W. L. Law, “Prognostic factors affecting survival and recurrence of patients with pT1 and pT2 colorectal cancer,” World Journal of Surgery, vol. 31, no. 7, pp. 1485–1490, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. S. B. Lim, C. S. Yu, S. J. Jang, T. W. Kim, J. H. Kim, and J. C. Kim, “Prognostic significance of lymphovascular invasion in sporadic colorectal cancer,” Diseases of the Colon and Rectum, vol. 53, no. 4, pp. 377–384, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. M. G. House, H. Ito, M. Gönen et al., “Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1,600 patients during two decades at a single institution,” Journal of the American College of Surgeons, vol. 210, no. 5, pp. 744–752, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. P. Das, J. M. Skibber, M. A. Rodriguez-Bigas et al., “Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer,” American Journal of Clinical Oncology, vol. 29, no. 3, pp. 219–224, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. K. Lang, J. R. Korn, D. W. Lee, L. M. Lines, C. C. Earle, and J. Menzin, “Factors associated with improved survival among older colorectal cancer patients in the US: a population-based analysis,” BMC Cancer, vol. 9, no. 1, article 227, 2009. View at Publisher · View at Google Scholar · View at PubMed
  13. G. J. C. Harris, A. J. Senagore, I. C. Lavery, J. M. Church, and V. W. Fazio, “Factors affecting survival after palliative resection of colorectal carcinoma,” Colorectal Disease, vol. 4, no. 1, pp. 31–35, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. W. L. Law and K. W. Chu, “Anterior resection for rectal cancer with mesorectal excision: a prospective evaluation of 622 patients,” Annals of Surgery, vol. 240, no. 2, pp. 260–268, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. A. N. Meguerditchian, I. Bairati, R. Lagacé, F. Harel, and A. Kibrité, “Prognostic significance of lymphovascular invasion in surgically cured rectal carcinoma,” American Journal of Surgery, vol. 189, no. 6, pp. 707–713, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. F. Mehrkhani, S. Nasiri, K. Donboli, A. Meysamie, and A. Hedayat, “Prognostic factors in survival of colorectal cancer patients after surgery,” Colorectal Disease, vol. 11, no. 2, pp. 157–161, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. J. W. Huh, H. R. Kim, and Y. J. Kim, “Prognostic value of perineural invasion in patients with stage II colorectal cancer,” Annals of Surgical Oncology, vol. 17, no. 8, pp. 2066–2072, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. M. S. Kahlenberg, D. L. Stoler, M. A. Rodriguez-Bigas et al., “p53 tumor suppressor gene mutations predict decreased survival of patients with sporadic colorectal carcinoma,” Cancer, vol. 88, no. 8, pp. 1814–1819, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. V. E. Pricolo, S. D. Finkelstein, K. Hansen, B. F. Cole, and K. I. Bland, “Mutated p53 gene is an independent adverse predictor of survival in colon carcinoma,” Archives of Surgery, vol. 132, no. 4, pp. 371–375, 1997. View at Google Scholar · View at Scopus
  20. R. Rajaganeshan, R. Prasad, P. J. Guillou et al., “The influence of invasive growth pattern and microvessel density on prognosis in colorectal cancer and colorectal liver metastases,” British Journal of Cancer, vol. 96, no. 7, pp. 1112–1117, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. R. Rajaganeshan, D. G. Jayne, H. Z. Malik et al., “Biological characteristics and behaviour of putatively curatively resected colorectal liver metastases,” European Journal of Surgical Oncology, vol. 34, no. 4, pp. 439–444, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus